On Thursday, Carnival Corp (NYSE:CCL)’s shares declined -0.25% to $52.74.
After achieving a $5 million fundraising aim for St. Jude Children’s Research Hospital®, Carnival Cruise Line has declared an additional $10 million aim by 2020, while ongoing its role as the hospital’s Official Celebration Partner.
The declaration was made by Carnival President Christine Duffy at the hospital in Memphis, Tennessee , during the cruise line’s third annual Day of Play which this year featured a variety of Dr. Seuss-themed activities for patients and their families. At the event, Carnival officials presented the hospital with an oversized check for $5 million , representing the funds raised for St. Jude over the past two years – a full two years ahead of plan. Carnival has raised $8 million in total for the hospital since the start of their partnership in 2010.
St. Jude Children’s Research Hospital is leading the way the world understands, treats and defeats childhood cancer and other life-threatening diseases. Unlike any other hospital, the majority of funding for St. Jude comes from individual contributions. Thanks to generous donors, families never receive a bill from St. Jude for treatment, travel, housing or food – because all a family should worry about is assisting their child live.
Carnival Corporation operates as a cruise company worldwide. It provides vacations to various cruise destinations. The company offers cruise services under the Carnival Cruise Lines, Holland America Line, Princess Cruises, and Seabourn brand names in North America; and AIDA Cruises, Costa Cruises, Cunard, and P&O Cruises names in Europe, Australia, and Asia. It operates 100 cruise ships.
MannKind Corporation (NASDAQ:MNKD)’s shares dropped -1.10% to $3.60.
MannKind Corporation (MNKD) declared the renewal of its shelf Registration Statement on Form S-3, as filed with the Securities and Exchange Commission, replacing the previous shelf which expired on August 31, 2015. Conpresently, MannKind also renewed its At-The-Market Issuance Sales Agreements with Meyers Associates, L.P. (now doing business as BP Capital, a division of Meyers Associates, L.P.) and with MLV & Co. LLC providing for sales, from time to time, of the Company’s common stock.
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes in the United States. Its lead product is AFREZZA inhalation powder, an insulin to control high blood sugar in adult patients with type 1 and type 2 diabetes.
At the end of Thursday’s trade, Manulife Financial Corporation (USA) (NYSE:MFC)‘s shares dipped -1.94% to $15.66.
Manulife Investments, a division of Manulife Asset Administration Limited (MAML), recently declared a number of projected changes to its mutual fund lineup. The changes follow the acquisition of the Canadian-based operations of Standard Life plc accomplished earlier this year and are part of the ongoing integration of the Standard Life Mutual Funds into the Manulife fund family. Subject to applicable regulatory and securityholder approval, Manulife Investments proposes to:
- amalgamate the existing Standard Life and Manulife mutual fund corporations.
- change the investment objectives of certain funds.
- change the sub-advisors and portfolio managers of certain funds.
- cap certain funds to new purchases.
- implement a series of fund mergers.
In an effort to create a stronger mutual fund corporation and to allow for tax-deferred switching between the Standard Life corporate funds and the Manulife corporate funds, in addition to tax-deferred mergers between these funds, Manulife Investments is proposing to amalgamate Standard Life Corporate Class Inc. (“SLCCI”) and Manulife Investment Exchange Funds Corp., on a tax-deferred basis, into a single corporate entity (the “Corporate Amalgamation”).
Manulife Financial Corporation, together with its auxiliaries, provides financial protection and wealth administration products and services to individual, corporate, and business customers primarily in Asia, Canada, and the United States.
Penn West Petroleum Ltd (USA) (NYSE:PWE), ended its Thursday’s trading session with -3.49% loss, and closed at $0.550.
PENN WEST PETROLEUM LTD. (PWE) declare that it has reached a definitive agreement for the sale of its properties in the Greater Mitsue area of Central Alberta for cash consideration of $192.5 million, subject to closing adjustments customary in transactions of this nature. We intend to use the proceeds from this disposition to reduce our senior debt. Upon the completion of the sale of our Mitsue properties, we will have raised about $605 million in total proceeds this year through our non-core asset disposition program. In addition, since the end of Q2 2013, we will have divested an estimated 34,000 boe/d of non-core assets for proceeds of about $1.7 billion, which has allowed us to reduce our debt by about $1.4 billion, representing a reduction of more than 40%.
Penn West Petroleum Ltd. explores for, develops, and produces oil and natural gas properties in western Canada. The company’s properties are located in Alberta, British Columbia, Saskatchewan, Manitoba, and the Northwest Territories, Canada; and Wyoming, the United States. As of March 12, 2015, it operated a portfolio of opportunities in light oil in Canada covering a land base of about 4.5 million acres.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
